TrialPloS one2011

Prediction of effect of pegylated interferon alpha-2b plus ribavirin combination therapy in patients with chronic hepatitis C infection.

Tetsuro Takayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.